Group items tagged

Blind Girl Can See Thanks to Umbilical Cord-Based Adult Stem Cell Treatment London, England (LifeNews.com) -- Born two years ago with severe eye problems, Dakota Clarke could not even see well enough to recognize her own mother and father. But now the parents of the little girl, who is registered blind, say she can make out their faces for the first time after pioneering stem cell treatment. The couple gave up work to raise well over $40,000 to fly their daughter to China for the treatment, which remains at the experimental level in Britain -- because the nation has been too preoccupied with embryonic stem cells and human cloning. They returned home this week convinced that Dakota can now see colors, lights and objects around her as a result. They hope further therapy will give her a lifetime of sight. "It's nothing short of a miracle for us," said Mr Clarke, a former engineer. "She can see the world for the first time." In Dakota's case, cells were administered intravenously through her hairline and reportedly traveled towards her optic nerve, repairing the damaged area. The stem cells came from umbilical cords donated by Chinese mothers. Despite the obvious success, some doctors are talking down the results simply because the treatments aren't approved in England. Pro-life advocates say the results are yet another showing of how adult stem cells outpace their embryonic cousins both ethically and when used in treatments.

Sulbutiamine (brand name: Arcalion) is a precursor to thiamine (i.e., vitamin B1). As a dimer of two structurally modified thiamine residues, sulbutiamine retains many of the features of thiamine. However, the thiazole rings are open, the alcohol groups are esterified, and a disulfide bridge connects the two thiamine analogues. Sulbutiamine is indicated for the treatment of asthenia.[1] Its ability to reduce fatigue is also considered desirable by athletes, and it is available for over-the-counter sale as a nutritional supplement. In one study of chronic fatigue patients, sulbutiamine did not demonstrate sustained benefits over the placebo, which raises doubts about its clinical efficacy.[2] However, the authors of that study suggest that additional research is needed to evalulate the potential usefulness of sulbutiamine in the treatment of chronic fatigue. Sulbutiamine may be beneficial for cognition. Indeed, the demonstrated ability of sulbutiamine to improve memory in rats[3] and patients of schizophrenia[3] suggests that it is a nootropic. Recent research also shows support for the use of sulbutiamine in the treatment of erectile dysfunction

Sometimes but however yet a healthy person might have to deal with the Erectile Dysfunction Problems or impotence treatment . Medical drugs specially targeting your condition can to a great extent reduce the Erectile Dysfunction Problems now and then all the way to get rid of it. A well chosen erectile dysfunction treatment will really improve blood flow in the penile area and also increase the working ability of the muscles and nerves that responsible for the erection for Erectile Dysfunction Problems . Some

Scientists have developed the first "personalised" drug shown to be effective against advanced melanoma, the deadliest type of skin cancer which is on the rise in Britain. Warnings about the risks of melanoma were heightened this weekend as the fine weather drew thousands to sunbathe outdoors, putting them at increased risk. "Binge tanning", where sunbathers allow their skin to burn in their eagerness to get a tan, is a key cause of the cancer. Melanoma, which starts as a blemish or change to a mole on the skin, is treatable in its early stages but once it has spread to other organs such as the lungs and liver there are no treatment options. Patients with melanoma that has spread usually die within months

Green Beans for Cancer Prevention and Treatment.

Vitamin K in the treatment and prevention of osteoporosis and arterial calcification.\nAdams J, Pepping J.\nAm J Health Syst Pharm. 2005 Aug 1;62(15):1574-81. Review.\nPMID: 16030366

Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. \nVitamin D in the treatment of pulmonary tuberculosis.\nJ Steroid Biochem Mol Biol. 2007 Mar;103(3-5):793-8. Epub 2007 Jan 12. Review.\nPMID: 17223549 [PubMed - indexed for MEDLINE]

Mice injected with cancer cells experienced significantly elevated levels of C-reactive protein, white blood cells, and lipid peroxidation compared with control mice. These levels were reduced in animals that received cisplatin and/or DHA. While treatment with 125 mg/kg DHA inhibited tumor growth by 38 percent compared to untreated animals, 250 mg/kg suppressed tumor growth by 79 percent, which was a greater effect than that of cisplatin alone (which was associated with a 55 percent reduction). The combination of DHA and cisplatin resulted in an 81 percent inhibition of growth, while reducing elevated white blood cell levels (leukocytosis) to normal levels. Treatment with the higher dose of DHA alone was associated with a similar reduction in white blood cells, which, when elevated, are associated with tumor growth. A strong relationship was observed between tumor growth and white blood cell levels as well as C-reactive protein levels. In another experiment with rats treated with cisplatin, the addition of 250 mg/kg DHA prevented lethal kidney toxicity in 88 percent of the animals that received it, while none of the rats that received cisplatin alone survived.

Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.\nLucas M, Asselin G, Mérette C, Poulin MJ, Dodin S.\nAm J Clin Nutr. 2009 Feb;89(2):641-51. Epub 2008 Dec 30.\nPMID: 19116322 \ndoi:10.3945/ajcn.2008.26749

A very deceptive cancer that affects the prostate, does not start early, but does grow fast once it does start. This cancer like many can be life threatening as well as very damaging.

Fish oil and treatment of cancer cachexia. Giacosa A, Rondanelli M. Genes Nutr. 2008 Apr;3(1):25-8. PMID: 18850196

Treatment of most forms of SLE involves suppression of the immune system, as summarized in Table I. The most commonly used immunosuppressive drugs for moderately severe lupus are the corticosteroids, such as prednisone. These agents effectively suppress disease activity for most patients, but they also have many undesirable side effects.

WASHINGTON, Feb 26 (Reuters) - An antibody being developed by a Dutch drug company chokes off both seasonal flu and the H5N1 avian flu virus and might offer a way to develop better treatments and vaccines, researchers reported on Thursday.

Taking a combination of vitamins B6 and B12 and folic acid appears to decrease the risk of age-related macular degeneration in women, according to a report in the February 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Age-related macular degeneration (AMD) is a leading cause of vision loss in older Americans, according to background information in the article. Treatment options exist for those with severe cases of the disease, but the only known prevention method is to avoid smoking. Recent studies have drawn a connection between AMD and blood levels of homocysteine, an amino acid. High levels of homocysteine are associated with dysfunction of the blood vessel lining, whereas treatment with vitamin B6, vitamin B12 and folic acid appears to reduce homocysteine levels and may reverse this blood vessel dysfunction.

Pomegranate fruit extracts have been shown to block enzymes that contribute to cartilage degradation in osteoarthritis, a condition that currently has little perspective for treatment. The findings, although still at a preliminary stage not yet proven in humans, are likely to encourage further consumption of pomegranate juice in the UK, where sales have rocketed in the last year thanks to media coverage of its antioxidant content.

Apple cider vinegar is also used as a skin toner, bacterial douche, sunburn treatment and a weight loss supplement.

ScienceDaily (May 12, 2009) - Taking folic acid supplements for at least a year before conception is associated with reduction in the risk of premature birth, according to a study by Radek Bukowski (from the University of Texas Medical Branch, United States of America) and colleagues. Although most pregnancies last about 40 weeks, many babies (for example around 12% in the United States) are born before 37 completed weeks of pregnancy. Babies born prematurely are less likely to survive than full-term babies and are more likely to have breathing difficulties and learning or developmental disabilities. Currently, there are no effective methods of prevention or treatment of premature (preterm) birth, but previous studies have suggested that lower concentrations of folate (folic acid) are associated with shorter duration of pregnancy. Bukowski and colleagues therefore tested this idea, by analyzing data collected from a cohort of nearly 35,000 pregnant women. The results of this study showed that taking folate supplements for at least one year before conception was associated with a 70% reduction in spontaneous premature birth between 20 and 28 weeks (a reduction from 0.27% to 0.04%), and a 50% reduction between 28 and 32 weeks (reduction from 0.38% to 0.18%), as compared to the rate of preterm birth when mothers did not take additional folate supplementation. Folate supplementation for less than a year before conception was not linked to a reduction in the risk of premature birth in this study, and folate supplementation was not associated with any other complications of pregnancy. In a related commentary also published in this week's PLoS Medicine, Nicholas Fisk from the University of Brisbane, Australia, and colleagues (who were not involved in the original study) say "Methodologically, the study has several strengths... It is based on a huge dataset, with prospective recording of dietary supplements and potential confounders, and gestational age determined accu

Now a new and controversial book by an American doctor suggests that taking even higher levels of the vitamin - 10 to 15 times the recommended amounts - can work wonders. Dr James Dowd, who works at the Arthritis Institute of Michigan, has been prescribing vitamin D to people suffering from chronic disorders such as arthritis, back pain and headaches and the result, he claims, is a huge improvement in their symptoms. In his book, The Vitamin D Cure, Dr Dowd describes a number of success stories using this approach. One of his patients, Barbara, for instance, was obese, and suffered from arthritis in one leg as well as high blood pressure. As Dowd explains: "In the past I would have given her anti-inflammatory drugs, pain medication, a pill to lose weight and drug treatment for hypertension."